Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Oligodendroglioma 1Head and Neck Neoplasms 1Glioblastoma 1Carcinoma, Squamous Cell 1Carcinoma 1Astrocytoma 1

Interventions

Cisplatin 5Cetuximab 3Radiotherapy 2Petrolatum 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2temoporfin 1talazoparib 1ruxolitinib 1peginterferon alfa-2a 1olaparib 1fluoromisonidazole 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1cemiplimab 1cedazuridine 1atezolizumab 1aldesleukin 1Vorinostat 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiation 1Narrow Band Imaging 1Interviews as Topic 1Interleukin-2 1Gefitinib 1Decitabine 1DNA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Squamous Cell × DNA × Clear all
NCT02211027 2017-09-07

Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡